@article{e00451acee3349959cf5716f358bb6c8,
title = "Synthesis, characterization, and imaging of radiopaque bismuth beads for image-guided transarterial embolization",
abstract = "Current therapy for hypervascular cancers, e.g., hepatocellular carcinoma, includes occlusion of the tumor blood supply by arterial infusion of embolic microspheres (beads) suspended in iodine-based contrast under fluoroscopic guidance. Available radiopaque, imageable beads use iodine as the radiopacifier and cannot be differentiated from contrast. This study aimed to synthesize and characterize imageable beads using bismuth as the radiopacifier that could be distinguished from iodine contrast based upon the difference in the binding energy of k-shell electrons (k-edge). Radiodense bismuth beads were successfully synthesized some with uniform bismuth distribution across the beads. The beads were spherical and could be infused through clinical microcatheters. The bismuth beads could be imaged with clinical dual-energy computed tomography (CT), where iodine-based contrast could be distinguished from the microspheres. The ability to separate iodine from bismuth may enhance the diagnostic information acquired on follow-up CT, identifying the distribution of the embolic beads separately from the contrast. Furthermore, with sequential use of iodine- and bismuth-based beads, the two radiopaque beads could be spatially distinguished on imaging, which may enable the development of dual drug delivery and dual tracking.",
author = "Negussie, {Ayele H} and {de Ruiter}, {Quirina M B} and Hugh Britton and Donahue, {Danielle R} and Quentin Boffi and Young-Seung Kim and Pritchard, {William F} and Chrit Moonen and Gert Storm and Lewis, {Andrew L} and Wood, {Bradford J}",
note = "Funding Information: This work was supported by the Center for Interventional Oncology in the Intramural Research Program of the National Institutes of Health (NIH) by intramural NIH Grants NIH Z01 1ZID BC011242 and CL040015. The NIH and Biocompatibles UK Ltd (BTG/Boston Scientific) have a Cooperative Research and Development Agreement, which provided funding for the conduct of the study. NIH and Biocompatibles UK Ltd have intellectual property in the field. Thanks to Dr. Martin W. Brechbiel, Radioimmune & Inorganic chemistry Section, Radiation Oncology Branch, NCI, Drs. John Lloyd and Noel Whittaker, NIDDK Advanced Mass Spec Core Facility for recording mass spectroscopy data, and Dr. Belhu Metaferia, NIDDK, National Institutes of Health, for fruitful discussion. Thanks to Jayasai Rajagopal for constructive discussion on the DECT imaging, and to Amir Pourmorteza, David Bluemke, and Elizabeth Jones for discussion of photon-counting CT and Kevin Tixier for his help on taking images of beads with an upright microscope. Publisher Copyright: {\textcopyright} 2021, The Author(s).",
year = "2021",
month = dec,
doi = "10.1038/s41598-020-79900-z",
language = "English",
volume = "11",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",
}